To amend the Federal Food, Drug, and Cosmetic Act and Public Health Service Act to advance the next-generation of clinical development of novel treatments and cures, and for other purposes.

Voted 10/22/2026View source

Summary

No summary has been published for this bill yet. The Congressional Research Service writes summaries after a bill is introduced, so recent bills often have none.

Bill text

The full text of this bill isn't on Heard yet. Use the source link above to read it at the official source.

Roll-call record

How representatives voted

0 yea·0 nay

No roll-call votes recorded for this bill yet.